Sickle cell disease (SCD), one of the most common monogenetic diseases in the world, is
associated with multisystemic complications that begin in childhood. Most of the babies …

Sickle cell disease (SCD) is an umbrella term for a group of life‐long debilitating autosomal
recessive disorders that are caused by a single‐point mutation (Glu→ Val) that results in …

Sickle cell disease (SCD) is a single gene disorder causing a debilitating systemic
syndrome characterised by chronic anaemia, acute painful episodes, organ infarction and …

Objectives Sickle cell disease (SCD) encompasses health complications, primarily affecting
the hematologic system and leading to high death rates in childhood. As a rule, the World …

The vast majority of the world's population of children and adults with sickle cell disease
(SCD) are born in low-resource settings, particularly in sub-Saharan Africa, the Caribbean …

Over the past decades there has been a significant improvement in the care of patients with
sickle cell disease (SCD) in high-income countries. However, more needs to be learned …

Sickle cell disease (SCD) is a genetic blood disorder affecting red blood cells, with high
morbidity and mortality rates. The United Nations has recognized SCD as a global public …

Objectives We used the National Health Interview Survey (NHIS) data set to examine the
prevalence of comorbid medical conditions; explore barriers to accessing healthcare and …

Sickle cell disease (SCD) is a common inherited disease affecting 12–15,000 individuals in
the UK with approximately 250 new births per annum. Life expectancy has improved with the …

About seven per cent of the world's population is a carrier of globin-gene mutations1, of
which the sickle gene is one of the most common and the most pathogenic [sickle cell …